MRI may replace invasive biopsies for urinary tract cancer diagnosis

NCT ID NCT07252882

Not yet recruiting Diagnosis Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to see if a special MRI scan can accurately diagnose invasive upper urinary tract tumors. About 178 adults with suspicious findings on a CT scan will receive an MRI, and the results will be compared to standard biopsy or follow-up CT. If successful, MRI could offer a non-invasive way to diagnose these cancers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAGNETIC RESONANCE IMAGING (MRI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign urinary system neoplasm malignant urinary system neoplasm renal pelvis/ureter urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MAGNETIC RESONANCE IMAGING (MRI) UROLOGIC CANCER

Contacts and locations

Locations

CHU de Toulouse

Toulouse, France, 31059, France
Clinique Beau Soleil

Montpellier, France, 34070, France
Clinique La Croix du Sud

Quint-Fonsegrives, France, 31130, France
Clinique Pasteur

Toulouse, France, 31076, France
Hôpital Claude Huriez

Lille, France, 59037, France
Hôpital Européen Georges Pompidou

Paris, France, 75015, France
Hôpital Lapeyronie

Montpellier, France, 34295, France
Hôpital Pellegrin

Bordeaux, France, 33000, France
Hôpital Saint-Louis

Paris, France, 75010, France
Hôpital de la Pitié Salpêtrière

Paris, France, 75013, France
Institut Paoli Calmettes

Marseille, France, 13009, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.